A

AFC-HD AMS Life Science Co Ltd
TSE:2927

Watchlist Manager
AFC-HD AMS Life Science Co Ltd
TSE:2927
Watchlist
Price: 867 JPY 0.7% Market Closed
Market Cap: ¥12.6B

AFC-HD AMS Life Science Co Ltd
Other Non-Cash Items

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

AFC-HD AMS Life Science Co Ltd
Other Non-Cash Items Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Other Non-Cash Items CAGR 3Y CAGR 5Y CAGR 10Y
A
AFC-HD AMS Life Science Co Ltd
TSE:2927
Other Non-Cash Items
¥440.7m
CAGR 3-Years
N/A
CAGR 5-Years
25%
CAGR 10-Years
25%
Shiseido Co Ltd
TSE:4911
Other Non-Cash Items
¥50.5B
CAGR 3-Years
N/A
CAGR 5-Years
45%
CAGR 10-Years
N/A
Rohto Pharmaceutical Co Ltd
TSE:4527
Other Non-Cash Items
-¥4.9B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Kao Corp
TSE:4452
Other Non-Cash Items
-¥3.4B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
F
Fancl Corp
TSE:4921
Other Non-Cash Items
¥1.1B
CAGR 3-Years
N/A
CAGR 5-Years
37%
CAGR 10-Years
11%
Kobayashi Pharmaceutical Co Ltd
TSE:4967
Other Non-Cash Items
¥6.9B
CAGR 3-Years
N/A
CAGR 5-Years
103%
CAGR 10-Years
N/A
No Stocks Found

AFC-HD AMS Life Science Co Ltd
Glance View

Market Cap
12.6B JPY
Industry
Consumer products

AFC-HD AMS Life Science Co., Ltd. engages in the manufacture of health food and cosmetics. The company is headquartered in Shizuoka-Shi, Shizuoka-Ken and currently employs 793 full-time employees. The company went IPO on 2005-03-03. The firm is engaged in the research and development, product design, manufacture and sale of health foods and cosmetics, manufacture and sale of Chinese medicine medicines, general medicines, generic medicines, healthcare products, the sale of natural foods, as well as planning of health information programs. The firm operates in two business segments. The Healthcare segment is engaged in the manufacture and sale of health foods and cosmetics, as well as the provision of original equipment manufacturers (OEM). The Pharmaceutical segment is engaged in the manufacture and sale of ethical drugs and over-the-counter drugs, as well as the sale of generic drugs. The firm is also engaged in the management of restaurants through subsidiary.

Intrinsic Value
976.78 JPY
Undervaluation 11%
Intrinsic Value
Price ¥867
A

See Also

What is AFC-HD AMS Life Science Co Ltd's Other Non-Cash Items?
Other Non-Cash Items
440.7m JPY

Based on the financial report for Feb 28, 2026, AFC-HD AMS Life Science Co Ltd's Other Non-Cash Items amounts to 440.7m JPY.

What is AFC-HD AMS Life Science Co Ltd's Other Non-Cash Items growth rate?
Other Non-Cash Items CAGR 10Y
25%

Over the last year, the Other Non-Cash Items growth was 542%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett